What this study is
Acute kidney injury (AKI) affects up to 20% of hospitalized Veterans and is strongly associated with morbidity and death. AKI is a diverse condition and timely and accurate diagnosis of the type of AKI is critical to begin appropriate therapies, especially those causes that require specific treatments beyond general supportive care. Yet, there are still significant gaps in the initial evaluation of AKI among hospitalized patients. Clinical decision support systems (CDSS) have shown promise to address these barriers, but most consist of simple alerting schemes and general care recommendations provided at a single point in time. The goal of this proposal is to develop and test the feasibility and usability of a rule-based and Artificial Intelligence-assisted precision CDSS tool (PRECISE-AKI) that can provide cognitive support to improve timely initial diagnostic evaluation of AKI.
What's being tested
- PRECISE-AKI Clinical Decision Support Tool
Intervention · OTHER
The Intervention arm will consist of Clinical Decision Diagnostic Support (CDS) provided by the PRECISE-AKI tool
Study details
- Sponsor
- VA Office of Research and Development
- Conditions
- Acute Kidney Injury (AKI)
- Enrolling
- 60 people
- Starts
- 2028-01-01
- Est. completion
- 2029-06-30
- Design
- Single-blind, non-randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Eligible providers will be those that have at least 4 weeks of inpatient ward team or consultation team activity during a 12-month period
- Case inclusion criteria will consist of hospitalizations that meet criteria for Kidney Disease Improving Global Outcomes Stage 2 injury or persistent Stage 1 injury seen by eligible providers
You can't join if
- Ineligible providers will be those that have < 4 weeks of inpatient ward team of consultative team activity during a 12 month period
- Hospitalizations with non-persistent (<48 hours) stage 1 injury or less
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openTennessee Valley Healthcare System Nashville Campus, Nashville, TN
Nashville, Tennessee, United States
- Michele Lenoue-Newton, PhD · Contact(615) 936-6728michele.lenoue-newton@va.gov
- Edward D Siew, MD MSc · Principal investigator
- Michael E Matheny, MD MS MPH · Principal investigator
Study team
Sponsor
VA Office of Research and Development
Study ID HSR3-017-24W
Principal investigator
Edward D Siew, MD MSc
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Principal investigator
Michael E Matheny, MD MS MPH
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.